Home
Flashcards
Preview
pharmacy practice III
Home
Get App
Take Quiz
Create
obesity associated morbidity and mortality
CVD
type II DM
respiratory problems
gallbladder disease
osteoarthritis
Anorexic BMI
<17.5
underweight BMI
17.5-18.4
Normal Weight
18.5-24.9
Overweight
25-29.9
Obese
> or = 30
metabolic syndrome risk factors
Waist circumference 40 inch (men) 35 inch (women)
triglycerides >= 150mg/dL
HDL men< 40mg/dL women <50mg/dL
blood pressure >= 130/85 mmHg
fasting blood glucose >= 100 mg/dL
weight gain results from
energy intake > energy expenditure
one pound of adipose tissue
3500 calories
Environment pathophysiology
activity level
food availability
increase in portion size and calorie density
occupation
sleep duration
energy homeostasis
basal metabolism 60-70%
thermogenesis 10%
physical activity 15-30%
satiety (pathophysiology)
leptin
ghrelin
GLP-1
Medications (pathophysiology)
atypical antipsychotics (respiradone, quetiapine)
hormonal contraceptives
steroids
anticonvulsants (valporic acid, lithium)
insulin
goals of therapy
reduce body weight by 5-10% over 6 months
maitenance of weight loss
prevent future weight gain
exclusions to self-treatment
severe obesity (BMI > 40)
pregnancy or breast-feeding
< 18 or > 65 years
eating disorders
comprehensive lifestyle modification
dietary change
physical activity
behavior therapy
pharmacotherapy treatment
BMI > 30
BMI > 27 + co-morbidities
short term vs long term
single therapy vs. comination therapy
lowest effective doses
should be used with concomitant lifestyle changes
average adult man calorie intake
2200-3000 kCal/day
average adult woman
1800-2800 kCal/day
weight loss cal reduction
300-1000 per day
low cal diet (LCD)
800-1500 kCal/day
goal is to lose 1-2 lbs per wk
very low cal diet (VLCD)
< 800 kCal/day
goal is to lose 2-4lbs/ wk
must be conducted under supervisor
Dietary change (exercise)
adults should exercise for at least 30 min and children for at least 60 min for most days
low fat diet
30% of total
8-10% of total calories from saturated fat
include more mono/polyunsaturated fats
inadequate to lose weight (must be a reduce tot calories)
very low fat vegetarian diets
possible benefit in patients with CHD
must choose dietary fat carefully to avoid deficiency
meal replacement therapy advantage/servings/replacement
portion control
usual serving = 200-300 calories
-low fat selection
-low carbohydrate selection
replace 1-2 meals/day (eat reasonable 3rd meal)
Physical activity for adults/children
children and adolescents >= 60 min of mod/vigorous activity every day
adults 150 min of moderate aerobic exercise or 75 min of vigorous physical activity
behavior therapy
group or individual therapy (group may be better)
face to face communication
diet planning
online food diary tracking
environmental modification (eliminate high density cal food)
thinking pattern modification
optimistic approach
encouragement from others
Orlistat
Alli
only FDA approved non Rx drug
ages >= 18
Alli MOA
decreases fat absorption
-inhibiting pancreatic and gastric lipases
-inhibiting hydrolysis of FAs
Alli Dosing/Goal
60mg PO TID with meals (should contain fat)
goal is 5-10 lb loss over 6 months
Alli AE
flatulence
oily spotting
loose/frequent, fatty stools
fecal urgency and incontinence
symptoms are worst over first two months then improve
Alli drug interactions
warfarin
cyclosporine
levothyroxine
amiodarone
oral hypoglycemic agents
consult PCP bere starting orlistat
thyroid disease
DM
kidney stones (nephrolithiasis)
gall stones (cholelithiasis)
pancreatitis
should not be used in patients with a malabsorption disorder
Alli patient education
take multivitamin at bedtime
should be used in combination with lifestyle changes
side effects can be minimized by reducing the amount of ingested fat
bannned products
phenylpropanolamine
ephedra/ma huang
Aloe + cascara sagrada
Author
alvo2234
ID
185985
Card Set
pharmacy practice III
Description
pharmacy practice III final (overweight and obesity)
Updated
2012-11-29T15:50:36Z
Show Answers
Home
Flashcards
Preview